Contraception Medicines Approved in the EU (EMA)

Medicines the European Medicines Agency has recommended for use in the European Union on this topic.

Each number has its full source under its own list below.

Medicines authorised in the EU

5 medicines (authorised now). Newest first. Each links to its EMA page.

At the source
  • Lydisilka

    Active substance: estetrol monohydrate;drospirenone

    EMEA/H/C/005382
  • Drovelis

    Active substance: drospirenone;estetrol monohydrate

    EMEA/H/C/005336
  • Zoely

    Active substance: nomegestrol acetate;estradiol

    EMEA/H/C/001213
  • ellaOne

    Active substance: ulipristal

    EMEA/H/C/001027
  • Evra

    Active substance: norelgestromin;Ethinyl estradiol

    EMEA/H/C/000410

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

Benchmarks on contraception

Countries side by side on public measures for this topic.

All benchmarks

EU medicine approvals on related topics

All topics

Acuitas market sizes and forecasts are only in our full reports. How we use public data.